Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories

Divis Laboratories

BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 27, 14:54
630.60
-13.6 (-2.11%)
VOLUME 90,490
LIVE
NSE
Apr 27, 14:52
631.05
-12.45 (-1.93%)
VOLUME 510,615
News on Divis Laboratories
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
What changed for market while you were sleeping? 12 things to know

8.01 am | 24 Apr 2017 |  Source: Moneycontrol.com

A look at the top cues from domestic and international markets that could have a bearing on the D-Street on Monday....

USFDA issues warning letter to Divis Labs for Vizag unit

3.19 pm | 22 Apr 2017 |  Source: PTI

Drug firm Divis Laboratories today said the US health regulator has issued a warning letter to the company for its Vishakhapatnam facility....

US FDA issues warning letter to Visakhapatnam unit-II of Divi's Lab 

1.26 pm | 22 Apr 2017 |  Source: CNBC-TV18

In a setback for Divi's Lab, the US FDA has issued a warning letter for the company's unit-II at Visakhapatnam. Ekta Batra has more details....

Hold Divis Laboratories for long term: Prakash Gaba 

3.48 pm | 17 Apr 2017 |  Source: CNBC-TV18

Prakash Gaba of prakashgaba.com is of the view that one may hold Divis Laboratories for long term....

Hold Divi's Laboratories; target of Rs 690: Axis Direct

1.20 pm | 11 Apr 2017 |  Source: Moneycontrol.com

Axis Direct recommended hold rating on Divi's Laboratories with a target price of Rs 690 in its research report dated April 10, 2017....

Top buzzing midcap stocks to trade on April 10 

12.45 pm | 10 Apr 2017 |  Source: CNBC-TV18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - Divis Laboratories, Welspun India, AB Fashion, T...

USFDA exempts more products from import alert: Divis Labs 

6.40 pm | 08 Apr 2017 |  Source: PTI

The regulator had earlier exempted 10 products, including Levetiracetam, Gabapentin, Lamotrigine, Capecitabine, Naproxen sodium and BOC core succinate...

Buy, Sell, Hold: What stocks and sectors are analysts betting on?

8.40 am | 28 Mar 2017 |  Source: CNBC-TV18

Analysts' views on Kotak Mahindra Bank, IndusInd Bank, Divi's Laboratories as well as the media sector....

Due to exempted products, import alert from FDA to hit only 5% of Divi's sales: CFO

12.40 pm | 27 Mar 2017 |  Source: Moneycontrol.com

Company to seek exemption of more products...

Buy YES Bank, Aditya Birla Nuvo, Bata India; sell M&M, Apollo Hospitals: Sudarshan Sukhani 

10.17 am | 24 Mar 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy YES Bank, Aditya Birla Nuvo and Bata India and sell M&M and Apollo Hospitals....

Earnings to be next trigger for market; steer clear of Bharat Fin: Dimensions Chief 

10.32 am | 23 Mar 2017 |  Source: CNBC-TV18

Ajay Srivastava of Dimensions Consulting feels the earnings trajectory could determine the direction in which the market will move going forward. He i...

Divis Laboratories: Updates on USFDA alert

9.14 am | 23 Mar 2017 |  Source: Moneycontrol.com

The company has already initiated necessary measures to address the concerns raised by the US-FDA and is making all efforts to fully meet the complian...

Stocks in the news: Axis, IOB, Rel Defence, InterGlobe, Sadbhav Infra, Idea, PVR 

8.24 am | 23 Mar 2017 |  Source: CNBC-TV18

Axis Bank | Hindustan Zinc | Divis Labs | IOB | Shah Alloys | Reliance Defence | InterGlobe Aviation | PVR | Muthoot Finance | Equitas Holdings | Vist...

Top buzzing midcap stocks to trade on March 22 

12.40 pm | 22 Mar 2017 |  Source: CNBC-TV18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today Divis Laboratories, Delta Corp, Apollo Tyres, NLC India, To...

Buy, Sell, Hold: Are these stocks present in your portfolio?

8.47 am | 22 Mar 2017 |  Source: Moneycontrol.com

Motilal Oswal has initiated coverage with a buy rating and has set a target price at Rs 229....

A message for Indian pharma: Do what you say, say what you do

9.34 pm | 21 Mar 2017 |  Source: CNBC-TV18

Over the last decade, “data integrity” has turned out to be the most discussed and perhaps the most dreaded word for the Indian pharmaceutical com...

Expect 15-20% cut in Divis Labs' FY18-FY19 EPS estimates: HDFC Sec 

4.19 pm | 21 Mar 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Amey Chalke, Pharma Analyst at HDFC Securities shared his readings and outlook on Divis Laboratories and Dr Reddys Labor...

Six in Sixty: Stocks you should keep on your radar 

2.42 pm | 21 Mar 2017 |  Source: CNBC-TV18

CNBC-TV18's Ekta Batra lists out stocks that you should focus on....

Buy L&T, HUL; sell Apollo Hospitals, Idea Cellular; avoid Dr Reddy's Labs: Sudarshan Sukhani 

1.54 pm | 21 Mar 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy L&T and HUL and sell Apollo Hospitals and Idea Cellular while one can avoid D...

Top buzzing midcap stocks to trade on March 21

1.14 pm | 21 Mar 2017 |  Source: CNBC-TV18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- Divis Laboratories, Idea Cellular, Dr Reddys Laboratorie...

1 2 3 4 5
Quick Links for Divis Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.